{"entity":{"type":"insider","cik":"0001712276","url":"/insider/0001712276","json_url":"/insider/0001712276.json","name":"Taylor Ben R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2019-06-17","last":"2026-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Taylor Ben R","source":"filing","n_filings":4,"first_seen":"2019-06-17","last_seen":"2026-03-18"}],"transactions":[{"id":5767299,"accession":"0001712276-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001712276-26-000002","line_url":"/filing/0001712276-26-000002#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001712276","owner_name":"Taylor Ben R","owner_url":"/insider/0001712276","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7956.0,"shares_display":"7,956","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":26970.84,"total_display":"26,970.84","shares_owned_after":1180318.0,"shares_owned_after_display":"1,180,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-18","scope":"insider"},{"id":6039603,"accession":"0001601830-26-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601830-26-000020","line_url":"/filing/0001601830-26-000020#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001712276","owner_name":"Taylor Ben R","owner_url":"/insider/0001712276","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13426.0,"shares_display":"13,426","price_per_share":3.08,"price_display":"3.08","price_state":"stated","total_value":41352.08,"total_display":"41,352.08","shares_owned_after":1195349.0,"shares_owned_after_display":"1,195,349","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-19","scope":"insider"},{"id":4546461,"accession":"0001712276-25-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001712276-25-000017","line_url":"/filing/0001712276-25-000017#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001712276","owner_name":"Taylor Ben R","owner_url":"/insider/0001712276","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21383.0,"shares_display":"21,383","price_per_share":4.18,"price_display":"4.18","price_state":"stated","total_value":89380.94,"total_display":"89,380.94","shares_owned_after":761550.0,"shares_owned_after_display":"761,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-29","filed_date":"2025-12-30","scope":"insider"},{"id":8437400,"accession":"0000899243-19-017151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-017151","line_url":"/filing/0000899243-19-017151#line-1","is_derivative":false,"issuer_cik":"0001537917","issuer_name":"TYME TECHNOLOGIES, INC.","issuer_ticker":"TYME","issuer_name_source":null,"issuer_url":"/issuer/0001537917","owner_cik":"0001712276","owner_name":"Taylor Ben R","owner_url":"/insider/0001712276","role":"Officer (President, CFO)","officer_title":"President, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":10100.0,"total_display":"10,100.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-14","filed_date":"2019-06-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001601830","name":"RECURSION PHARMACEUTICALS, INC.","url":"/issuer/0001601830","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2025-12-30","last_seen":"2026-03-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001537917","name":"TYME TECHNOLOGIES, INC.","url":"/issuer/0001537917","role":"Officer (President, CFO)","n_filings":1,"first_seen":"2019-06-17","last_seen":"2019-06-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001712276","retrieved_at":"2026-08-21T07:12:57+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}